Por: ABC News Health August 04, 2023
A new immunization to protect infants from was approved by the Centers for Disease Control and Prevention on Thursday.The approved drug called nirsevimab, which will be marketed in the U.S. by Sanofi as Beyfortus, was recommended unanimously by the CDC's Advisory Committee on Immunization Practice for all children under 8 months old and signed off on by CDC director Dr. Mandy Cohen, the last step in the regulatory process.It comes less than... + full article
ABC News USA Health September 08, 2023
The Centers for Disease Control and Prevention this week that cases of respiratory syncytial virus, or RSV, are rising among young children in some parts of the Southeastern United States.Traditionally, RSV season begins in the fall and continues through the winter, similar to... + más
What Are the Duties of A Trustee? | Forbes
Rare silver coin from first Jewish revolt against Roman Empire discovered | Newsweek
Los Angeles Times USA Nation September 06, 2023
An increase in the Southeast of respiratory syncytial virus, better known as RSV, may be an early sign of the start of the respiratory virus season. A health advisory issued by the U.S. Centers for Disease Control and Prevention on Tuesday said there were elevated cases of RSV... + más
NFL Week 17 playoff picture and clinching scenarios: Bucs win NFC South; Giants clinch wild card | ESPN
New York Post USA Life July 18, 2023
The Food and Drug Administration on Monday approved a new drug, Beyfortus (nirsevimab), to protect young children from the deadly infection known as . Worldwide, RSV is the second-leading cause of death during the first year of a newborn’s life, second only to , according to .... + más
Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS
Strong RSV vaccine data lifts hopes after years of futility | ABC News
New York Post USA Life February 23, 2023
A vaccine to protect against severe cases of Respiratory Syncytial Virus could roll out as early as August. Pfizer has developed RSVpreF, a vaccine to prevent severe cases of RSV, and the Food and Drug Administration is reportedly expediting its review approval process. The FDA... + más
Strong RSV vaccine data lifts hopes after years of futility | WPLG Local 10
Forbes USA Tech November 28, 2022
Child in the hospital bed using nebulizer to relieve cough. getty The United States has already plunged into one of the roughest seasons of winter illnesses in decades. After nearly three years of being sequestered, children and adults are back out in crowds, with no masks, no... + más
A 'tripledemic' of flu, RSV and COVID is feared in California | Los Angeles Times
RSV and the ‘Tripledemic’: What you need to know | WGN-TV
CNBC USA Health November 11, 2022
Diane Macdonald Stockbyte Getty ImagesEven healthy infants face a considerable risk of hospitalization from respiratory syncytial virus, according to a large European study published Thursday.Dutch and British scientists, in a study published in Lancet Respiratory Medicine,... + más
Pfizer says study shows vaccinating pregnant women protects newborns from RSV | ABC7
10 WBNS USA Health November 01, 2022
NEW YORK — shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals each fall. The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be... + más
About iurex | Privacy Policy | Disclaimer |